Literature DB >> 26967580

Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium.

Takuya Hashimoto1, Kota Yamamoto1, Trenton Foster2, Hualong Bai2, Kunihiro Shigematsu3, Alan Dardik4.   

Abstract

Delivery of therapeutic agents to enhance arteriovenous fistula (AVF) maturation can be administered either via intraluminal or external routes. The simple murine AVF model was combined with intraluminal administration of drug solution to the venous endothelium at the same time as fistula creation. Technical aspects of this model are discussed. Under general anesthesia, an abdominal incision is made and the aorta and inferior vena cava (IVC) are exposed. The infra-renal aorta and IVC are dissected for clamping. After proximal and distal clamping, the puncture site is exposed and a 25 G needle is used to puncture both walls of the aorta and into the IVC. Immediately after the puncture, a reporter gene-expressing viral vector was infused in the IVC via the same needle, followed by 15 min of incubation. The intraluminal administration method enabled more robust viral gene delivery to the venous endothelium compared to administration by the external route. This novel method of delivery will facilitate studies that explore the role of the endothelium in AVF maturation and enable intraluminal drug delivery at the time of surgical operation.

Entities:  

Mesh:

Year:  2016        PMID: 26967580      PMCID: PMC4828216          DOI: 10.3791/53905

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  21 in total

1.  Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimal hyperplasia of vein grafts in cholesterol-fed rabbit: a limited biological effect as a result of the loss of medial smooth muscle cells.

Authors:  Shinji Ohta; Kimihiro Komori; Yoshikazu Yonemitsu; Toshihiro Onohara; Takuya Matsumoto; Keizo Sugimachi
Journal:  Surgery       Date:  2002-06       Impact factor: 3.982

2.  Efficient transgene expression from naked DNA delivered into an arterio-venous fistula model for kidney dialysis.

Authors:  Anat S Globerman; Malka Chaouat; Zippora Shlomai; Eithan Galun; Evelyn Zeira; Gideon Zamir
Journal:  J Gene Med       Date:  2011-11       Impact factor: 4.565

Review 3.  Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations.

Authors:  J J Escobar-Chávez; M López-Cervantes; A Naïk; Y N Kalia; D Quintanar-Guerrero; A Ganem-Quintanar
Journal:  J Pharm Pharm Sci       Date:  2006       Impact factor: 2.327

4.  Technical aspects of the mouse aortocaval fistula.

Authors:  Kota Yamamoto; Xin Li; Chang Shu; Tetsuro Miyata; Alan Dardik
Journal:  J Vis Exp       Date:  2013-07-11       Impact factor: 1.355

5.  Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE*3Leiden mice.

Authors:  Jacco C Karper; Margreet R de Vries; Ben T van den Brand; Imo E Hoefer; Jens W Fischer; J Wouter Jukema; Hans W M Niessen; Paul H A Quax
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-02-17       Impact factor: 8.311

6.  Induction of cardiac hypertrophy by a controlled reproducible sutureless aortocaval shunt in the mouse.

Authors:  Tony Karram; Aaron Hoffman; Bishara Bishara; Sergey Brodsky; Eliahu Golomb; Joseph Winaver; Zaid Abassi
Journal:  J Invest Surg       Date:  2005 Nov-Dec       Impact factor: 2.533

7.  Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.

Authors:  Jonathan A Hata; Jason A Petrofski; Jacob N Schroder; Matthew L Williams; Sarah H Timberlake; Anne Pippen; Michael T Corwin; Amy K Solan; Andre Jakoi; Thomas R Gehrig; Christopher D Kontos; Carmelo A Milano
Journal:  J Thorac Cardiovasc Surg       Date:  2005-06       Impact factor: 5.209

8.  The mouse aortocaval fistula recapitulates human arteriovenous fistula maturation.

Authors:  Kota Yamamoto; Clinton D Protack; Masayuki Tsuneki; Michael R Hall; Daniel J Wong; Daniel Y Lu; Roland Assi; Willis T Williams; Nirvana Sadaghianloo; Hualong Bai; Tetsuro Miyata; Joseph A Madri; Alan Dardik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-04       Impact factor: 4.733

9.  Early and sustained medial cell activation after aortocaval fistula creation in mice.

Authors:  Raul J Guzman; Andrew Krystkowiak; Christopher K Zarins
Journal:  J Surg Res       Date:  2002-11       Impact factor: 2.192

10.  Adventitial transduction of lentivirus-shRNA-VEGF-A in arteriovenous fistula reduces venous stenosis formation.

Authors:  Binxia Yang; Rajiv Janardhanan; Pawan Vohra; Eddie L Greene; Santanu Bhattacharya; Sarah Withers; Bhaskar Roy; Evelyn C Nieves Torres; Jaywant Mandrekar; Edward B Leof; Debabrata Mukhopadhyay; Sanjay Misra
Journal:  Kidney Int       Date:  2013-08-07       Impact factor: 10.612

View more
  1 in total

1.  Hypoxia and hypoxia-inducible factors promote the development of neointimal hyperplasia in arteriovenous fistula.

Authors:  Nirvana Sadaghianloo; Julie Contenti; Serge Declemy; Damien Ambrosetti; Masa Zdralevic; Mounia Tannour-Louet; Lucilla Fabbri; Gilles Pagès; Frédéric Bost; Réda Hassen-Khodja; Jacques Pouysségur; Elixène Jean-Baptiste; Alan Dardik; Nathalie M Mazure
Journal:  J Physiol       Date:  2021-03-19       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.